Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
Comments Off on Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
March 4, 2026
The CBD endometriosis trial backed by the NHS is entering its dosing phase, offering hope for better pain management. This trial focuses on cannabidiol's role in treating chronic pelvic pain associated with endometriosis. Access to clinical trial data…
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in Rheumatic Diseases
Comments Off on Efficacy, Tolerability, and Safety of Cannabinoid Treatments in Rheumatic Diseases
May 24, 2022
The focus on cannabinoid treatments rheumatic diseases highlights their potential in managing pain and inflammation. This systematic review examines efficacy, tolerability, and safety data from randomized controlled trials. Findings suggest cautious…